Kedrion Biopharma is a dynamic and growing biopharmaceutical company, specializing in the development and production of plasma-derived products to address many serious, often rare, diseases and conditions. Our portfolio includes, among others, therapies for Hemophilia, Primary Immunodeficiencies, and Rh sensitization as well as more widely used products like Albumin. Our interest in rare diseases and conditions is confirmed by our acquisition of Prometic and its new therapy for Congenital Plasminogen Deficiency. Our headquarters are in Tuscany, Italy, where the company was founded and grew to become a significant partner to the Italian National Health System. Today it is one of the world leaders in the production of plasma-derived products which it distributes in some one hundred countries. Working on a vertically integrated business model, Kedrion Biopharma is engaged on all aspects of the production of its products, from plasma collection to development and manufacturing cycles to distribution. We operate collection centers in the US and production plants in Italy, the United States, Canada and Hungary. Kedrion’s partnership with the Italian Health System has resulted in unique expertise which we offer in support of countries and systems pursuing self-sufficiency in the availability of plasma-derived therapies.  

Founded in 1894, Ghella is a leading company in the construction of major infrastructure projects worldwide. With its unique skills and experience in underground works, Ghella is involved in the construction of many infrastructure projects such as subways, railways, motorways and major roads, significant water and hydraulic works. While still having its corporate office in Rome, Italy, the Company has most of its workload in the international markets, mostly in Oceania, Far East, Latin America, and Europe. The Company specializes in tunneling and has successfully implemented more than 200 km of tunnels and has also accumulated the previous experiences of using TBM Earth Pressure Balance (EPB). Ghella opened a Representative Office in Hanoi in July of 2015. On the 30th of October 2015 the joint venture (JV) Hyundai Engineering & Construction (Korean) and Ghella (Italy) signed a Contract with the Hanoi Metropolitan Railway Management Board (MRB) to build 4,1km of underground works including a bi-tube tunnel and four stations. This project is the largest and most important one among the nine packages of Hanoi Pilot Metro Line Project, Nhon - Hanoi railway station section (Metro Line 3) and the first underground metro project in the capital city of Vietnam. Ghella’s primary interests in Vietnam are the metro lines in Hanoi and Ho Chi Minh City as well as all those underground works which require extensive experiences of using TBM Earth Pressure Balance (EPB).